The Good News
Policy & Ethics
Where science meets society: regulatory decisions, research ethics, public health policy, and the debates around how scientific knowledge is applied, funded, and communicated.
Reporters love an apocalypse, even when they have to invent one.
My friends Dan and Diane Henry lost their daughter to pain. Danielle began experiencing migraine disease when she was eight
This year marks the 10th anniversary of the passage of the amended Toxic Substances Control Act (TSCA).
Science is meant to be self-correcting, but is this true in practice?
A recent Atlantic essay, “The Cities That Said Yes to Drugs,” by Michael Powell, offers a disturbing
Once, an HIV/AIDS diagnosis meant virtually certain death. [1] That was before Gilead Pharmaceuticals developed the drug tenofovir in two “prodrug” forms [2], tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF).
Medicare Advantage (MA) accounts for an increasing share of overall Medicare coverage. The privatized program now serves 54% of eligible beneficiaries, and why not?
Join us on the Science Dispatch podcast as we discuss:
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
